Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

Faculty members

Julie Brake
Julie Brake
Nurse Consultant, Liverpool
Julie Brake started working as a Diabetes Specialist Nurse in 1994, with a specific focus on education, and involving people with diabetes more in their care. In 2002, Julie moved to the Royal Liverpool University Hospital where she now leads a large inpatient and outpatient diabetes specialist nursing team. Julie’s specialty clinics include diabetic nephropathy and CSII. Julie was the chair of the local research ethics committee for over 5 years and has a strong interest in research and audit.

Faculty members

Mags Bannister
Nurse Consultant, Bradford
Julie Brake

Diabetes Nurse
Consultant, Royal
Liverpool University

Sian Bodman

Senior Diabetes Nurse, South Wales
Nicola Milne
Community Diabetes Specialist Nurse, Manchester University Foundation Trust​
Helen Rogers

Nurse Consultant,

Sponsorship statement:
At the 4-Front: Leadership in Diabetes Nursing activities including the main Cohort programme and Faculty meeting, have been sponsored by Napp Pharmaceuticals Limited. Napp have had no input into the agenda or content of the 2020 programme.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.